| Le neoplasie neuroendocrine della mammella: inquadramento diagnostico e gestione clinica R Baldelli, R De Fata, R Buzzetti, P Zuppi, R Garcia-Carbonero, ... L'Endocrinologo, 1-5, 2024 | | 2024 |
| Rediscovering immunohistochemistry in lung cancer A La Salvia, ML Meyer, FR Hirsch, KM Kerr, L Landi, MS Tsao, ... Critical Reviews in Oncology/Hematology, 104401, 2024 | | 2024 |
| Gender-related differences in patients with carcinoid syndrome: new insights from an Italian multicenter cohort study RM Ruggeri, B Altieri, P Razzore, F Retta, E Sperti, G Scotto, MP Brizzi, ... Journal of Endocrinological Investigation 47 (4), 959-971, 2024 | 1 | 2024 |
| Authorship of Italian medical literature on neuroendocrine neoplasms: any gender gap? RE Rossi, A La Salvia, R Modica, F Spada Journal of Endocrinological Investigation, 1-7, 2024 | | 2024 |
| Rachel score: a nomogram model for predicting the prognosis of lung neuroendocrine tumors A La Salvia, B Marcozzi, C Manai, R Mazzilli, L Landi, M Pallocca, ... Journal of Endocrinological Investigation, 1-12, 2024 | 1 | 2024 |
| Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons R Modica, A La Salvia, A Liccardi, A Cozzolino, A Di Sarno, F Russo, ... Endocrine, 1-12, 2024 | 1 | 2024 |
| Thyroid transcription factor‐1 expression in lung neuroendocrine tumours: a gender-related biomarker? A La Salvia, A Siciliani, M Rinzivillo, M Verrico, R Baldelli, G Puliani, ... Endocrine 83 (2), 519-526, 2024 | 2 | 2024 |
| Metabolomic profile of neuroendocrine tumors identifies methionine, porphyrin, and tryptophan metabolisms as key dysregulated pathways associated with patient survival A La Salvia, A Lens-Pardo, A López-López, C Carretero-Puche, ... European Journal of Endocrinology 190 (1), 62-74, 2024 | | 2024 |
| Extrapulmonary Neuroendocrine Carcinomas: Current Management and Future Perspectives S Stumpo, MG Formelli, I Persano, E Parlagreco, E Lauricella, ... Journal of Clinical Medicine 12 (24), 7715, 2023 | | 2023 |
| Predictive Factors of Response to Streptozotocin in Neuroendocrine Pancreatic Neoplasms G Fanciulli, A La Salvia, S Di Molfetta, G Cannavale, G Puliani, M Verrico, ... Journal of Clinical Medicine 12 (24), 7557, 2023 | | 2023 |
| 2022P ALBA project: Prognostic impact of laterality in small cell lung cancer L Landi, B Resuli, A D'Incecco, A Tufman, K Cannita, G Minuti, ... Annals of Oncology 34, S1074, 2023 | | 2023 |
| 1191P TTF-1 expression in lung neuroendocrine tumors (NET): A gender-related biomarker A La Salvia, A Siciliani, M Rinzivillo, M Verrico, R Baldelli, G Puliani, ... Annals of Oncology 34, S704-S705, 2023 | | 2023 |
| Cell-based medicinal products approved in the European Union: current evidence and perspectives S Bellino, A La Salvia, MF Cometa, R Botta Frontiers in Pharmacology 14, 1200808, 2023 | 3 | 2023 |
| Neuroendocrine tumors: the road to precision medicine A La Salvia, D Giuffrida, R Modica Frontiers in Endocrinology 14, 1253319, 2023 | 2 | 2023 |
| Precision medicine in gastroenteropancreatic neuroendocrine neoplasms: Where are we in 2023? N Fazio, A La Salvia Best Practice & Research Clinical Endocrinology & Metabolism, 101794, 2023 | 8 | 2023 |
| Proposal of early CT morphological criteria for response of liver metastases to systemic treatments in gastroenteropancreatic neuroendocrine tumors: Alternatives to RECIST L de Mestier, M Resche‐Rigon, C Dromain, A Lamarca, A La Salvia, ... Journal of neuroendocrinology 35 (6), e13311, 2023 | 1 | 2023 |
| COVID-19 in patients with neuroendocrine neoplasms: 2-year results of the INTENSIVE study N Fazio, L Gervaso, TR Halfdanarson, M Sonbol, RA Eiring, S Pusceddu, ... Endocrine-Related Cancer 30 (6), 2023 | | 2023 |
| Proteasome inhibitors in medullary thyroid carcinoma: time to restart with clinical trials? G Fanciulli, R Modica, A La Salvia, EM Grossrubatscher, T Florio, F Ferraù, ... Frontiers in Endocrinology 14, 1145926, 2023 | 1 | 2023 |
| Targeting neuroendocrine tumors with octreotide and lanreotide: Key points for clinical practice from NET specialists A La Salvia, R Modica, RE Rossi, F Spada, M Rinzivillo, F Panzuto, ... Cancer Treatment Reviews, 102560, 2023 | 15 | 2023 |
| MicroRNA signature and integrative omics analyses define prognostic clusters and key pathways driving prognosis in patients with neuroendocrine neoplasms B Soldevilla, A Lens‐Pardo, P Espinosa‐Olarte, C Carretero‐Puche, ... Molecular Oncology 17 (4), 582-597, 2023 | 1 | 2023 |
